Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wagner, C.
Right arrow Articles by Seiden, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wagner, C.
Right arrow Articles by Seiden, L. S.
NEUROLOGY 1980;30:547
© 1980 American Academy of Neurology

Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate

C. Wagner, G. A. Ricaurte, C. E. Johanson, C. R. Schuster and L. S. Seiden

Department of Biopsychology (Mr. Wagner), the Department of Pharmacology and Physiology (Mr. Ricaurte and Dr. Sideden). and the Department of Psychiatry (Drs. Johanson and Schuster), University of Chicago, Chicago, IL.

Long-lasting depletion of dopamine and concomitant loss of dopamine uptake sites follow repeated administration of methylamphetamine to rats. We found similar effects after similar treatment with d-amphetamine, but not after treatment with methylphenidate. Methylphenidate also failed to produce long-term depletion of regional catecholamine levels in rhesus monkeys. These long-lasting alterations of the dopaminergic system suggest that amphetamines or their metabolites have toxic interactions with dopaminergic neurons, which do not occur with methylphenidate.

Address correspondence and reprint requests to Mr. Wagner, Department of Biopsychology, University of Chicago, 5848 South University Avenue, Chicago, IL 60637.

This study was supported in part by USPHS NIDA grants Nos. DA00250 and DA00085 and Research Scientist Awards DA00024 (C. R. Schuster) and MH10562 (L. S. Seiden). G. A. Ricaurte received support from the Insurance Medical Scientist Scholarship Fund (New York Life Insurance Co.).

Accepted for publication August 14, 1979.




This article has been cited by other articles:


Home page
J Atten DisordHome page
C. Advokat
Literature Review: Update on Amphetamine Neurotoxicity and Its Relevance to the Treatment of ADHD
J Atten Disord, July 1, 2007; 11(1): 8 - 16.
[Abstract] [PDF]


Home page
FASEB J.Home page
J. L. CADET, S. JAYANTHI, and X. DENG
Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis
FASEB J, October 1, 2003; 17(13): 1775 - 1788.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Yuan, B. J. Cord, U. D. McCann, B. T. Callahan, and G. A. Ricaurte
Effect of Glucoprivation on Serotonin Neurotoxicity Induced by Substituted Amphetamines
J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 831 - 839.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
I. N. KRASNOVA, M. T. MCCOY, B. LADENHEIM, and J. L. CADET
cDNA array analysis of gene expression profiles in the striata of wild-type and Cu/Zn superoxide dismutase transgenic mice treated with neurotoxic doses of amphetamine
FASEB J, September 1, 2002; 16(11): 1379 - 1388.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L.M. Smith, L. Chang, M.L. Yonekura, C. Grob, D. Osborn, and T. Ernst
Brain proton magnetic resonance spectroscopy in children exposed to methamphetamine in utero
Neurology, July 24, 2001; 57(2): 255 - 260.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
T. Ernst, L. Chang, M. Leonido-Yee, and O. Speck
Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study
Neurology, March 28, 2000; 54(6): 1344 - 1349.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
U. D. McCann, D. F. Wong, F. Yokoi, V. Villemagne, R. F. Dannals, and G. A. Ricaurte
Reduced Striatal Dopamine Transporter Density in Abstinent Methamphetamine and Methcathinone Users: Evidence from Positron Emission Tomography Studies with [11C]WIN-35,428
J. Neurosci., October 15, 1998; 18(20): 8417 - 8422.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
V. Villemagne, J. Yuan, D. F. Wong, R. F. Dannals, G. Hatzidimitriou, W. B. Mathews, H. T. Ravert, J. Musachio, U. D. McCann, and G. A. Ricaurte
Brain Dopamine Neurotoxicity in Baboons Treated with Doses of Methamphetamine Comparable to Those Recreationally Abused by Humans: Evidence from [11C]WIN-35,428 Positron Emission Tomography Studies and Direct In Vitro Determinations
J. Neurosci., January 1, 1998; 18(1): 419 - 427.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by AAN Enterprises, Inc.